Prostate Cancer

>

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Latest News

Image of man with text.
Identifying Patients Who Will Benefit From Intensified Prostate Cancer Treatment

July 12th 2025

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will benefit from intensified treatment.

The FDA granted FTD to TRE-515 & radioligand therapy for PSMA+ mCRPC: © stock.adobe.com.
Fast Track Status Granted by FDA to TRE-515 in Prostate Cancer

July 11th 2025

Image of prostate
Long-Term Outcomes Support NCCN Guidelines for Prostate Cancer

July 10th 2025

Image of doctor with text.
Erleada May Be a New Standard of Care for Some With Prostate Cancer

July 10th 2025

Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available: © stock.adobe.com.
FDA Approves Stoboclo and Osenvelt as Biosimilars Across Some Cancers

July 9th 2025

Educated Patient Resource Guide

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Resource guide for prostate cancer
Video Series
Video Interviews
Podcasts
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
CURE Cancer Horizons podcast logo
Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.

More News